US Stock MarketDetailed Quotes

Ovid Therapeutics (OVID)

Watchlist
  • 2.800
  • -0.070-2.44%
Close May 13 16:00 ET
  • 2.800
  • 0.0000.00%
Pre 07:00 ET
522.59MMarket Cap-13.33P/E (TTM)

Ovid Therapeutics (OVID) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-35.19%-13.9M
31.49%-38.33M
-3.99%-10.41M
14.23%-12.87M
66.52%-4.77M
38.38%-10.28M
-22.23%-55.96M
15.97%-10.01M
-49.29%-15.01M
-21.77%-14.26M
Net income from continuing operations
-65.98%-16.99M
34.12%-17.41M
204.43%9.66M
13.19%-12.16M
-154.98%-4.68M
12.48%-10.24M
49.50%-26.43M
39.61%-9.25M
-24.48%-14.01M
168.66%8.52M
Depreciation and amortization
-75.18%35K
-55.46%273K
-89.38%17K
-90.53%16K
-33.11%99K
3.68%141K
7.92%613K
14.29%160K
15.75%169K
227.59%148K
Other non cash items
-39.06%-324K
97.44%-844K
79.70%-299K
77.58%-148K
99.45%-164K
75.70%-233K
-1,861.44%-32.91M
-119.52%-1.47M
30.67%-660K
-7,825.65%-29.82M
Change In working capital
278.97%2.33M
-2,636.00%-4.1M
115.71%134K
3.09%-1.69M
-129.70%-1.24M
25.11%-1.3M
-106.29%-150K
-123.34%-853K
-6,117.24%-1.75M
507.79%4.19M
-Change in prepaid assets
283.33%110K
-300.44%-1.8M
-678.40%-1.45M
-34.75%522K
18.53%-818K
-107.03%-60K
164.91%899K
-71.10%250K
-55.21%800K
76.68%-1M
-Change in payables and accrued expense
278.76%2.22M
-119.45%-2.3M
308.34%2.3M
13.05%-2.21M
-122.03%-1.14M
52.06%-1.24M
-127.82%-1.05M
-139.55%-1.1M
-44.85%-2.55M
58.34%5.19M
-Change in other working capital
----
----
----
--0
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-35.20%-13.9M
31.49%-38.33M
-4.00%-10.41M
14.23%-12.87M
66.51%-4.77M
38.39%-10.28M
-22.23%-55.96M
15.98%-10.01M
-49.29%-15.01M
-21.78%-14.26M
Investing cash flow
Cash flow from continuing investing activities
16.62%5.95M
-191.32%-49.85M
-438.46%-72.06M
1,630.48%5.05M
-6.00%12.05M
-74.73%5.1M
2,216.01%54.59M
143.89%21.29M
106.70%292K
-36.10%12.82M
Net PPE purchase and sale
----
--0
--0
--0
--0
--0
-77.50%-71K
-69.23%-22K
166.67%4K
-385.71%-34K
Net intangibles purchase and sale
----
--0
--0
--0
----
----
7.22%-90K
100.00%26K
--0
----
Net business purchase and sale
----
----
----
----
----
----
--0
--0
--0
----
Net investment purchase and sale
16.62%5.95M
-191.05%-49.85M
-438.53%-72.06M
1,654.51%5.05M
-7.08%12.05M
-74.75%5.1M
624.55%54.75M
143.88%21.29M
106.61%288K
-57.02%12.97M
Net other investing changes
----
----
----
----
----
----
200.00%1K
----
----
----
Cash from discontinued investing activities
Investing cash flow
16.62%5.95M
-191.32%-49.85M
-438.45%-72.06M
1,630.48%5.05M
-6.00%12.05M
-74.73%5.1M
2,215.23%54.59M
143.89%21.29M
106.70%292K
-36.10%12.82M
Financing cash flow
Cash flow from continuing financing activities
684,376.92%88.98M
11,991.16%75.21M
75.18M
-60.53%15K
0
-94.30%13K
-97.96%622K
0
-83.04%38K
68.72%356K
Net common stock issuance
--62.17M
--75.12M
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
206,153.85%26.81M
-85.37%91K
--63K
-60.53%15K
--0
-94.30%13K
16.26%622K
--0
-83.04%38K
68.72%356K
Cash from discontinued financing activities
Financing cash flow
684,376.92%88.98M
11,991.16%75.21M
--75.18M
-60.53%15K
--0
-94.30%13K
-97.96%622K
--0
-83.04%38K
68.72%356K
Net cash flow
Beginning cash position
-46.57%15.08M
-2.55%28.23M
33.01%22.54M
-4.04%30.35M
-29.47%23.07M
-2.55%28.23M
-38.09%28.97M
-71.45%16.95M
-57.00%31.63M
-49.67%32.7M
Current changes in cash
1,668.89%81.03M
-1,654.19%-12.98M
-164.61%-7.29M
46.83%-7.8M
775.23%7.28M
-238.43%-5.17M
95.85%-740K
137.12%11.28M
-3.45%-14.68M
-112.58%-1.08M
Effect of exchange rate changes
---122K
---167K
----
----
----
--0
--0
----
----
----
End cash Position
316.16%96M
-46.57%15.08M
-46.57%15.08M
33.01%22.54M
-4.04%30.35M
-29.47%23.07M
-2.55%28.23M
-2.55%28.23M
-71.45%16.95M
-57.00%31.63M
Free cash flow
-35.20%-13.9M
31.69%-38.33M
-4.04%-10.41M
14.20%-12.87M
66.86%-4.77M
38.46%-10.28M
-22.21%-56.12M
16.01%-10M
-49.16%-15M
-21.84%-14.41M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -35.19%-13.9M31.49%-38.33M-3.99%-10.41M14.23%-12.87M66.52%-4.77M38.38%-10.28M-22.23%-55.96M15.97%-10.01M-49.29%-15.01M-21.77%-14.26M
Net income from continuing operations -65.98%-16.99M34.12%-17.41M204.43%9.66M13.19%-12.16M-154.98%-4.68M12.48%-10.24M49.50%-26.43M39.61%-9.25M-24.48%-14.01M168.66%8.52M
Depreciation and amortization -75.18%35K-55.46%273K-89.38%17K-90.53%16K-33.11%99K3.68%141K7.92%613K14.29%160K15.75%169K227.59%148K
Other non cash items -39.06%-324K97.44%-844K79.70%-299K77.58%-148K99.45%-164K75.70%-233K-1,861.44%-32.91M-119.52%-1.47M30.67%-660K-7,825.65%-29.82M
Change In working capital 278.97%2.33M-2,636.00%-4.1M115.71%134K3.09%-1.69M-129.70%-1.24M25.11%-1.3M-106.29%-150K-123.34%-853K-6,117.24%-1.75M507.79%4.19M
-Change in prepaid assets 283.33%110K-300.44%-1.8M-678.40%-1.45M-34.75%522K18.53%-818K-107.03%-60K164.91%899K-71.10%250K-55.21%800K76.68%-1M
-Change in payables and accrued expense 278.76%2.22M-119.45%-2.3M308.34%2.3M13.05%-2.21M-122.03%-1.14M52.06%-1.24M-127.82%-1.05M-139.55%-1.1M-44.85%-2.55M58.34%5.19M
-Change in other working capital --------------0------------------------
Cash from discontinued investing activities
Operating cash flow -35.20%-13.9M31.49%-38.33M-4.00%-10.41M14.23%-12.87M66.51%-4.77M38.39%-10.28M-22.23%-55.96M15.98%-10.01M-49.29%-15.01M-21.78%-14.26M
Investing cash flow
Cash flow from continuing investing activities 16.62%5.95M-191.32%-49.85M-438.46%-72.06M1,630.48%5.05M-6.00%12.05M-74.73%5.1M2,216.01%54.59M143.89%21.29M106.70%292K-36.10%12.82M
Net PPE purchase and sale ------0--0--0--0--0-77.50%-71K-69.23%-22K166.67%4K-385.71%-34K
Net intangibles purchase and sale ------0--0--0--------7.22%-90K100.00%26K--0----
Net business purchase and sale --------------------------0--0--0----
Net investment purchase and sale 16.62%5.95M-191.05%-49.85M-438.53%-72.06M1,654.51%5.05M-7.08%12.05M-74.75%5.1M624.55%54.75M143.88%21.29M106.61%288K-57.02%12.97M
Net other investing changes ------------------------200.00%1K------------
Cash from discontinued investing activities
Investing cash flow 16.62%5.95M-191.32%-49.85M-438.45%-72.06M1,630.48%5.05M-6.00%12.05M-74.73%5.1M2,215.23%54.59M143.89%21.29M106.70%292K-36.10%12.82M
Financing cash flow
Cash flow from continuing financing activities 684,376.92%88.98M11,991.16%75.21M75.18M-60.53%15K0-94.30%13K-97.96%622K0-83.04%38K68.72%356K
Net common stock issuance --62.17M--75.12M--------------0--0------------
Proceeds from stock option exercised by employees 206,153.85%26.81M-85.37%91K--63K-60.53%15K--0-94.30%13K16.26%622K--0-83.04%38K68.72%356K
Cash from discontinued financing activities
Financing cash flow 684,376.92%88.98M11,991.16%75.21M--75.18M-60.53%15K--0-94.30%13K-97.96%622K--0-83.04%38K68.72%356K
Net cash flow
Beginning cash position -46.57%15.08M-2.55%28.23M33.01%22.54M-4.04%30.35M-29.47%23.07M-2.55%28.23M-38.09%28.97M-71.45%16.95M-57.00%31.63M-49.67%32.7M
Current changes in cash 1,668.89%81.03M-1,654.19%-12.98M-164.61%-7.29M46.83%-7.8M775.23%7.28M-238.43%-5.17M95.85%-740K137.12%11.28M-3.45%-14.68M-112.58%-1.08M
Effect of exchange rate changes ---122K---167K--------------0--0------------
End cash Position 316.16%96M-46.57%15.08M-46.57%15.08M33.01%22.54M-4.04%30.35M-29.47%23.07M-2.55%28.23M-2.55%28.23M-71.45%16.95M-57.00%31.63M
Free cash flow -35.20%-13.9M31.69%-38.33M-4.04%-10.41M14.20%-12.87M66.86%-4.77M38.46%-10.28M-22.21%-56.12M16.01%-10M-49.16%-15M-21.84%-14.41M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More